GPs face high multiples, 'creative' Ebitda adjustments to find deals: Riverside's Kriscunas

11 December 2018•2 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.